Published :
Updated :
For all latest news, follow The Financial Express Google News channel.
The Danish Investment Fund for Developing Countries (IFU) invested USD 12.5 million in AKS Khan Pharmaceuticals, to expand quality, accessible medicines and diagnostics to 8.0 million patients annually.
Senior officials including AKS Holdings Chairman, AK Samsuddin Khan and IFU Chief Executive Officer (CEO), Lars Bo Bertram were present at the signing ceremony at a star hotel in the capital on Wednesday night, according to a press release.
The investment from IFU will enable AKPL to reach 8.0 million patients annually within five years, expanding its ecosystem of pharmacies and diagnostics, and scaling up innovative services including home X-ray and ultrasound for vulnerable and elderly patients.
A major component of the growth strategy will focus on increasing the company’s presence beyond the capital.